2025 Annual Report of Independent Director
(Yi Ruofeng)
To all shareholders and shareholder representatives:
As an independent director of Starry Technology Co., Ltd. (hereinafter referred to as the "Company"), during my term of office in 2025, I strictly followed the "Company Law of the People's Republic of China" (hereinafter referred to as the "Company Law"), the "Articles of Association," and the "Independent Director Work System" and other relevant regulations, faithfully performed my duties, fully exercised the role of an independent director, and protected the legitimate rights and interests of the Company and all shareholders. The following is a report on my performance during my term of office in 2025:
I. Basic Information of Independent Directors
(I) Work Experience, Professional Background, and Concurrent Positions of Independent Directors
Mr. Yi Ruofeng, born in May 1977, is a Chinese national with no permanent overseas residency and holds a bachelor's degree from Jinan University. From July 1999 to April 2007, he served as an assistant auditor, auditor, and project manager at Lixin Certified Public Accountants Guangdong Branch. From April 2007 to December 2015, he served as Deputy General Manager of the Finance Center, Deputy General Manager of the Group Regulation and Audit Center, General Manager of the External Investment Management Center, and General Manager of Fangyuan Overseas Investment Company at Fangyuan Group Holdings Co., Ltd. From January 2016 to November 2023, he served as Executive Director, Company Representative, and member of the Remuneration Committee at Fangyuan Lifestyle Services Group Co., Ltd. Since December 2023, he has served as Executive Director of TOTORO HOLDING LIMITED. Since July 2024, he has served as the financial controller of Guanhansheng Biotechnology Co., Ltd. Since May 2024, he has served as an independent director of the Company.
(II) Statement of Independence
In addition to serving as an independent director of the Company, neither I nor my spouse, parents, children, nor other principal social relations hold any positions in the Company or its affiliated companies, nor do they hold any positions in the Company's principal shareholders. There are no conflicts of interest or other relationships that may hinder independent and objective judgment between me and the Company or its principal shareholders, which meets the requirements of the "Management Measures for Independent Directors of Listed Companies" and the "Shenzhen Stock Exchange Listed Company Self-Regulatory Guidelines No. 2 - Standardized Operation of GEM Listed Companies" regarding the independence of independent directors.
II. Overview of Independent Director's Performance in 2025
(I) Attendance at Board and Shareholder Meetings
In 2025, during my term of office, the Company held 6 board meetings and 2 shareholder meetings. I attended all of the aforementioned meetings. In accordance with the "Company Law," "Articles of Association," "Board Meeting Rules of Procedure," and "Independent Director Work System" and other relevant regulations and requirements, I carefully reviewed the proposals and related materials deliberated at the meetings, maintained sufficient communication with the Company's management, actively participated in the discussion of various issues, and offered reasonable suggestions, which played a positive role in the Company's correct decision-making.
In 2025, the convening and holding procedures of the Company's board and shareholder meetings complied with legal procedures, and major business decision-making matters and other major matters underwent the relevant approval procedures. During my term of office in 2025, I voted in favor of all proposals submitted to the Company's board of directors, with no dissenting opinions, no opposing votes, and no abstentions.
In 2025, I attended 6 meetings of the Board Audit Committee, 4 meetings of the Board Remuneration and Nomination Committee, 1 meeting of the Nomination Committee, 1 meeting of the Strategy Committee (renamed "Strategy and ESG Committee"), and 1 meeting of the Independent Directors' Special Committee. I voted in favor of all proposals at these meetings, with no dissenting opinions, no opposing votes, and no abstentions, thereby conscientiously performing my duties.